Skip to main content
    T

    Treace Medical Concepts Inc (TMCI)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $4.42
    -0.85 (-16.13%)

    Market Cap: $345.50M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Treace Medical Concepts Inc (TMCI) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Treace Medical Concepts are Neuropace (NPCE), Orthofix Medical (OFIX) and Tactile Systems Technology (TCMD). By market cap, Treace Medical Concepts ranks 8th of the 13 companies on this page; Integra LifeSciences Holdings (IART) is the largest at $1.12B. The median P/E of the 5 companies with a P/E is 23.7x.

    Peer Comparison

    TMCI's ROIC of -32.8% is below the peer median of -9.9%, and its revenue growth of -3.9% is below the median of 10.1%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Treace Medical Concepts (TMCI)$345.50MN/A1.4x-27.4%-32.8%-3.9%0.00%
    Neuropace Inc (NPCE)$260.45MN/A2.9x-17.7%-16.7%-1.1%0.00%
    Orthofix Medical Inc (OFIX)$292.25MN/A0.3x-5.4%-3.3%1.1%0.00%
    Tactile Systems Technology Inc (TCMD)$600.58M23.7x1.7x6.7%N/A7.1%0.00%
    Avita Medical Ltd (RCEL)$491.10MN/A5.5x-42.6%-159.3%53.1%0.00%
    Cerus Corporation (CERS)$400.88MN/A1.6x-3.2%-0.2%9.5%0.00%
    Brainsway Ltd (BWAY)$406.96M27.8x3.4x15.6%N/A35.4%0.00%
    Viemed Healthcare Inc (VMD)$347.48M24.1x1.1x5.0%11.1%12.2%0.00%
    Senseonics Holdings, Inc. Common Stock (SENS)$579.58MN/A11.9x-204.2%-71.4%141.6%0.00%
    Standard Biotools Inc (LAB)$279.27MN/A3.8x157.6%-9.9%-0.9%0.00%
    Neuronetics Inc (STIM)$134.10MN/A0.7x-14.4%-13.3%12.5%0.00%
    Integra LifeSciences Holdings (IART)$1.12B5.5x0.7x0.8%2.1%2.3%0.00%
    Electromed Inc (ELMD)$198.79M16.8x2.5x15.8%N/A10.6%0.00%
    Peer median$374.18M23.7x2.1x-1.2%-9.9%10.1%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Treace Medical Concepts, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Medical Devices.

    CompanyAboutPeers
    Neuropace Inc (NPCE)
    NeuroPace, Inc. is a medical device company in the United States. The company is headquartered in Mountain View, California.
    NPCE competitors
    Orthofix Medical Inc (OFIX)
    Orthofix Medical Inc. is a medical device and biological products company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally.
    OFIX competitors
    Tactile Systems Technology Inc (TCMD)
    Tactile Systems Technology, Inc., a medical technology company, is dedicated to the development and supply of medical devices for chronic diseases in the United...
    TCMD competitors
    Avita Medical Ltd (RCEL)
    AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom.
    RCEL competitors
    Cerus Corporation (CERS)
    Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety.
    CERS competitors
    Brainsway Ltd (BWAY)
    Brainsway Ltd., a commercial-stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel...
    BWAY competitors
    Viemed Healthcare Inc (VMD)
    Viemed Healthcare, Inc. provides durable home medical equipment and post-acute respiratory health care services to patients in the United States.
    VMD competitors
    Senseonics Holdings, Inc. Common Stock (SENS)
    Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United...
    SENS competitors
    Standard Biotools Inc (LAB)
    Standard Biotools Inc. (LAB) is a pioneering biotechnology company dedicated to enhancing genomic analysis and biological research through cutting-edge tools...
    LAB competitors
    Neuronetics Inc (STIM)
    Neuronetics, Inc., a commercial-stage medical technology company, designs, develops...
    STIM competitors
    Integra LifeSciences Holdings (IART)
    Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery...
    IART competitors
    Electromed Inc (ELMD)
    Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high-frequency chest wall oscillation...
    ELMD competitors

    Frequently Asked Questions About TMCI

    Who are Treace Medical Concepts' main competitors?

    The companies most similar to Treace Medical Concepts include Neuropace (NPCE), Orthofix Medical (OFIX), Tactile Systems Technology (TCMD), Avita Medical (RCEL) and Cerus (CERS), listed from the closest match.

    Who is Treace Medical Concepts' biggest competitor?

    Integra LifeSciences Holdings (IART) is the largest of the similar companies at $1.12B; Neuropace (NPCE) is the closest match by business profile, size, sector and industry.

    How does TMCI stock compare with its competitors?

    TMCI's P/S is 1.4x against a peer median of 2.1x; its net margin is -27.4% against a peer median of -1.2%.

    Which of Treace Medical Concepts' competitors pays a higher dividend?

    Treace Medical Concepts pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Treace Medical Concepts bigger than its competitors?

    No. Treace Medical Concepts is 8th by market cap among the 13 companies on this page; the largest is Integra LifeSciences Holdings (IART) at $1.12B.